UPDATED May 04, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ODD | US$33.60 | 4.4% | n/a | US$1.9b | US$53.14 | PE32.6x | E21.2% | n/a | Household | ||
WSC | US$37.35 | -3.5% | -15.6% | US$7.1b | US$51.70 | PE22.1x | E20.3% | n/a | Capital Goods | ||
VCTR | US$52.19 | 1.2% | 74.3% | US$3.4b | US$49.38 | PE15.8x | E28.1% | 2.6% | Diversified Financials | ||
DESP | US$12.30 | -4.0% | 119.3% | US$819.8m | US$13.42 | PS1.2x | E35.1% | n/a | Consumer Services | ||
ATLC | US$27.03 | -0.3% | -4.5% | US$395.0m | US$43.50 | PE5.1x | E19.2% | n/a | Diversified Financials | ||
OCUP | US$1.99 | 23.6% | -67.8% | US$51.0m | US$19.50 | PS2.7x | E9.5% | n/a | Pharmaceuticals & Biotech | ||
HTCR | US$0.87 | -5.3% | -12.0% | US$18.2m | US$3.00 | PB3.5x | E94.5% | 9.2% | Software | ||
FWRD | US$21.78 | -2.2% | -77.6% | US$574.3m | US$35.40 | PE13.7x | E30.7% | 0% | Transportation | ||
ZETA | US$12.82 | -0.5% | 53.7% | US$2.8b | US$15.35 | PS3.8x | E107.3% | n/a | Software | ||
FVRR | US$20.99 | 0.9% | -21.6% | US$812.4m | US$30.90 | PE220.7x | E56.9% | n/a | Commercial Services | ||
GAME | US$1.31 | -18.1% | -68.3% | US$39.7m | US$5.00 | PB2.2x | E100.9% | n/a | Media | ||
LUXH | US$0.84 | -18.5% | -70.8% | US$35.1m | US$5.83 | PE-0.4x | E96.7% | n/a | Real Estate Management and Development | ||
ULCC | US$5.76 | -5.9% | -28.8% | US$1.3b | US$7.64 | PB2.7x | E71.5% | 0% | Transportation | ||
CFFN | US$5.07 | 5.4% | -10.6% | US$657.4m | US$5.75 | PB0.6x | E140.7% | 6.7% | Banks | ||
ESPR | US$2.08 | 9.5% | 48.6% | US$394.0m | US$7.41 | PS3.4x | E59.5% | n/a | Pharmaceuticals & Biotech | ||
RVNC | US$3.95 | 16.2% | -88.6% | US$411.7m | US$16.33 | PS1.8x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
RSI | US$7.86 | 29.7% | 138.9% | US$1.8b | US$9.38 | PB10.3x | E104.1% | n/a | Consumer Services | ||
FSLR | US$191.55 | 7.2% | 7.3% | US$20.5b | US$227.60 | PE20x | E28.5% | n/a | Semiconductors | ||
GBT | US$68.49 | 0.6% | 169.5% | US$4.6b | US$68.50 | PS19.7x | E66.2% | n/a | Pharmaceuticals & Biotech | ||
AAOI | US$11.07 | 2.0% | 564.9% | US$428.7m | US$18.00 | PS2x | E134.2% | n/a | Tech | ||
HROW | US$10.38 | -1.4% | -61.7% | US$367.1m | US$25.65 | PS2.8x | E67.2% | n/a | Pharmaceuticals & Biotech | ||
RPD | US$45.21 | -1.6% | -3.6% | US$2.8b | US$59.66 | PS3.6x | E107.5% | n/a | Software | ||
CREX | US$3.35 | -4.0% | 25.0% | US$35.0m | US$7.13 | PB1.2x | E129.1% | n/a | Media | ||
ARCT | US$27.27 | 2.7% | 0.6% | US$734.3m | US$67.89 | PS4.4x | E60.0% | n/a | Pharmaceuticals & Biotech |